Search
pretomanid
Indications:
- for use in combination with bedaquiline & linezolid for treatment of adults with treatment-resistant pulmonary tuberculosis
Adverse effects:
- when use in combination with bedaquiline & linezolid
- peripheral neuropathy), acne, anemia, nausea, vomiting, headache, increased serum transaminases & serum gamma-glutamyltransferase, dyspepsia), rash, ihyperamylasemia, visual impairment, hypoglycemia, diarrhea
General
anti-mycobacterial agent
References
- FDA News Release. Aug 13, 2019
FDA approves new drug for treatment-resistant forms of tuberculosis
that affects the lungs.
https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-resistant-forms-tuberculosis-affects-lungs